123 related articles for article (PubMed ID: 2060155)
1. Antimalarial medications in dermatology. A review.
Weiss JS
Dermatol Clin; 1991 Apr; 9(2):377-85. PubMed ID: 2060155
[TBL] [Abstract][Full Text] [Related]
2. [Synthetic antimalarials and skin].
Ribrioux A
Ann Dermatol Venereol; 1990; 117(12):975-90. PubMed ID: 2150584
[No Abstract] [Full Text] [Related]
3. [Antimalarial drugs in contemporary dermatologic therapy].
Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
[TBL] [Abstract][Full Text] [Related]
4. Antimalarials in dermatology: mechanism of action, indications, and side effects.
Rodriguez-Caruncho C; Bielsa Marsol I
Actas Dermosifiliogr; 2014 Apr; 105(3):243-52. PubMed ID: 24656224
[TBL] [Abstract][Full Text] [Related]
5. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
7. Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus.
Ezra N; Jorizzo J
Clin Exp Dermatol; 2012 Jun; 37(4):327-34. PubMed ID: 22582908
[TBL] [Abstract][Full Text] [Related]
8. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
Jewell ML; McCauliffe DP
J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
[TBL] [Abstract][Full Text] [Related]
9. [Antimalarials in lupus erythematosus treatment].
Woźniacka A
Przegl Lek; 2002; 59(3):179-82. PubMed ID: 12184034
[TBL] [Abstract][Full Text] [Related]
10. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
Wallace DJ
Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
[TBL] [Abstract][Full Text] [Related]
11. Update on the management of cutaneous lupus erythematosus.
Callen JP
Br J Dermatol; 2004 Oct; 151(4):731-6. PubMed ID: 15491411
[TBL] [Abstract][Full Text] [Related]
12. Antimalarials.
Van Beek MJ; Piette WW
Dermatol Clin; 2001 Jan; 19(1):147-60, ix. PubMed ID: 11155579
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lupus erythematosus.
McCauliffe DP
Semin Cutan Med Surg; 2001 Mar; 20(1):14-26. PubMed ID: 11308132
[TBL] [Abstract][Full Text] [Related]
14. [Thalidomide in dermatology].
Hunziker T; Krebs A
Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
[TBL] [Abstract][Full Text] [Related]
15. Management of "refractory" skin disease in patients with lupus erythematosus.
Callen JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
[TBL] [Abstract][Full Text] [Related]
16. New concepts in antimalarial use and mode of action in dermatology.
Kalia S; Dutz JP
Dermatol Ther; 2007; 20(4):160-74. PubMed ID: 17970883
[TBL] [Abstract][Full Text] [Related]
17. [Beta-carotene treatment of protoporphyrias and polymorphic light dermatoses].
Barth J; Fickweiler E; Harnack K; Herrmann K; Hübner U; Schaarschmidt H; Schiller F
Dermatol Monatsschr; 1984; 170(4):244-8. PubMed ID: 6428940
[No Abstract] [Full Text] [Related]
18. Current treatment of cutaneous lupus erythematosus.
Werth V
Dermatol Online J; 2001 Feb; 7(1):2. PubMed ID: 11328623
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial drugs in pregnancy--the North American experience.
Parke AL; Rothfield NF
Lupus; 1996 Jun; 5 Suppl 1():S67-9. PubMed ID: 8803915
[TBL] [Abstract][Full Text] [Related]
20. beta-Carotene in the treatment of erythropoietic protoporphyria. A short review.
Krook G; Haeger-Aronsen B
Acta Derm Venereol Suppl (Stockh); 1982; 100():125-9. PubMed ID: 6819749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
